| Breakdown | TTM | Jan 2026 | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.92B | 38.31B | 38.63B | 35.95B | 32.57B | 27.72B |
| Gross Profit | 22.51B | 19.17B | 22.34B | 17.86B | 18.56B | 15.81B |
| EBITDA | 11.11B | 10.90B | 11.10B | 10.04B | 8.28B | 7.16B |
| Net Income | 5.89B | 5.98B | 5.87B | 5.38B | 4.13B | 3.24B |
Balance Sheet | ||||||
| Total Assets | 34.05B | 35.74B | 34.71B | 32.73B | 29.98B | 28.95B |
| Cash, Cash Equivalents and Short-Term Investments | 10.01B | 10.99B | 11.50B | 11.42B | 10.08B | 9.39B |
| Total Debt | 5.59B | 5.95B | 7.13M | 5.74B | 5.60B | 6.01B |
| Total Liabilities | 17.09B | 15.29B | 15.04B | 14.06B | 12.95B | 13.19B |
| Stockholders Equity | 16.95B | 20.45B | 19.68B | 18.64B | 17.01B | 15.73B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.76B | 6.62B | 6.80B | 5.26B | 5.63B |
| Operating Cash Flow | 0.00 | 8.87B | 9.29B | 8.67B | 6.67B | 6.75B |
| Investing Cash Flow | 0.00 | -3.09B | -3.29B | -1.71B | -3.50B | -3.25B |
| Financing Cash Flow | 0.00 | -6.80B | -6.61B | -5.47B | -4.61B | -3.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $68.14B | 28.12 | 36.70% | 0.90% | 3.71% | 0.65% | |
76 Outperform | $171.77B | 30.68 | 59.53% | 1.07% | 4.53% | 6.52% | |
74 Outperform | $182.85B | 28.57 | 32.34% | 3.76% | 6.10% | 6.04% | |
64 Neutral | $8.97B | 12.79 | 22.98% | 2.45% | 0.29% | 3.65% | |
63 Neutral | $19.99B | 13.49 | 34.82% | ― | 8.76% | 3.41% | |
62 Neutral | $19.63B | 31.09 | 39.79% | ― | 6.80% | 20.46% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |